+1 510 592 3000 info@tripleringtech.com


July 6, 2017 – AI in the Medtech and Healthcare Enterprise

AI is moving from consumer applications to the enterprise and is already affecting all parts of operations—from the customer to the product to the enterprise. Stephen Pratt, the CEO of Noodle.ai and former head of Watson for IBM GBS, presents a shareholder value perspective on why enterprise artificial intelligence (eAI) will be the single largest competitive differentiator in business over the next five years—and what you can do to end up on top.

We’ll discuss:

  • A framework for why AI is key to creating shareholder value
  • How to determine where to start and how to progress (with case studies)
  • How to manage spread of AI in your enterprise (with lessons from the past)
  • How to ensure proper adoption of AI solutions (implementing organizational change)
  • A future vision of the algorithmic enterprise

Steve Pratt will draw from his extensive expertise as a cutting-edge technologist, global strategist, innovator, and internationally renowned executive.

About the Speaker:

Stephen is an instigator, agitator, and pioneer in creating world-class technology services organizations. He has spent his career building innovative ways to create value for the world’s most important organizations. Prior to Noodle, he was responsible for all Watson implementations worldwide for IBM Global Business Services. He also was the founder and CEO of Infosys Consulting, a Senior Partner at Deloitte Consulting, and a technology and strategy consultant at Booz, Allen & Hamilton. He twice has been selected as one of the top 25 consultants in the world by Consulting Magazine. He has Bachelors and Masters degrees in Electrical Engineering from Northwestern University and The George Washington University focused on Satellite Communications. For fun, Steve plays competitive tennis, races sailboats, and formerly was a crazed rugby player. He enjoys playing acoustic guitar for his children (not ready for prime time).

Images are licensed under Creative Commons License.

Leave a reply

Your email address will not be published. Required fields are marked *


Providing space, support, and community for life science and medical device companies.

Please wait...